Advisors Capital Management LLC Has $30.83 Million Holdings in CME Group Inc. $CME

Advisors Capital Management LLC grew its position in shares of CME Group Inc. (NASDAQ:CME) by 2.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 112,901 shares of the financial services provider’s stock after purchasing an additional 2,914 shares during the quarter. Advisors Capital Management LLC’s holdings in CME Group were worth $30,831,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Brindle & Bay Financial Advisors LLC acquired a new position in CME Group in the fourth quarter valued at $735,000. AEGON ASSET MANAGEMENT UK Plc boosted its position in CME Group by 0.7% during the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 289,783 shares of the financial services provider’s stock valued at $79,134,000 after acquiring an additional 2,121 shares during the last quarter. Vanguard Group Inc. grew its holdings in CME Group by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after acquiring an additional 588,509 shares during the period. Impax Asset Management Group plc grew its holdings in CME Group by 6.9% during the 4th quarter. Impax Asset Management Group plc now owns 60,571 shares of the financial services provider’s stock worth $16,541,000 after acquiring an additional 3,899 shares during the period. Finally, Resonant Capital Advisors LLC raised its position in shares of CME Group by 32.4% in the 4th quarter. Resonant Capital Advisors LLC now owns 1,034 shares of the financial services provider’s stock worth $282,000 after acquiring an additional 253 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 4,200 shares of the stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the transaction, the director directly owned 43,007 shares in the company, valued at $13,317,117.55. This trade represents a 8.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the sale, the director owned 2,699 shares of the company’s stock, valued at $809,700. This trade represents a 21.70% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 8,539 shares of company stock valued at $2,713,821 in the last 90 days. 0.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on CME. Argus restated a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Morgan Stanley lowered their target price on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a report on Thursday. Weiss Ratings raised CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, March 2nd. TD Cowen cut their price target on CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a report on Thursday. Finally, Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, CME Group presently has an average rating of “Moderate Buy” and a consensus target price of $306.71.

CME Group Stock Performance

Shares of CME Group stock opened at $285.02 on Friday. CME Group Inc. has a one year low of $257.17 and a one year high of $329.16. The firm has a market capitalization of $102.22 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 3.02 and a beta of 0.26. The business has a 50-day simple moving average of $304.51 and a 200 day simple moving average of $286.23. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.03.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the prior year, the business earned $2.80 EPS. The firm’s revenue for the quarter was up 14.5% on a year-over-year basis. On average, research analysts anticipate that CME Group Inc. will post 12.26 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th were given a dividend of $1.30 per share. The ex-dividend date of this dividend was Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s payout ratio is currently 44.37%.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 revenue and volumes: CME reported record Q1 revenue and a surge in trading volumes, driven by higher hedging and risk-management activity — a core driver of futures and options trading revenue. Article Title
• Positive Sentiment: Earnings-call commentary backs the volume story: Management emphasized broad-based demand and rising market risk that is increasing hedging flows — a positive outlook for transaction-driven revenue. Article Title Article Title
• Positive Sentiment: Full earnings transcript available for deeper color: Investors can review management’s detail on volume drivers and segment performance. Article Title
• Neutral Sentiment: Multiple analysts trimmed price targets but kept constructive ratings: Deutsche Bank cut its PT to $322 (keeps buy) and TD Cowen cut to $323 (keeps buy); Morgan Stanley trimmed to $353 but retained overweight — these lower targets reflect model updates despite continued positive ratings. Article Title Article Title Article Title
• Neutral Sentiment: No meaningful short-interest signal: the short-interest data published for April is effectively zero/unchanged and does not explain the move. (No linked article.)
• Negative Sentiment: Goldman maintains a sell rating and lowered its PT to $267 — the most bearish big-bank view in the group and a direct negative for sentiment. Article Title
• Negative Sentiment: Mixed market reaction and some headline takes that Q1 sales missed analyst expectations or that the stock looks expensive post-earnings — these narratives can pressure short-term price action despite strong volume trends. Article Title Article Title

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.